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Abstract  
Background: The growth failure is one of the most significant problem in children with dilated cardiomyopathy, 
one third of those with  DCM have growth failure. Echocardiography regarded as  the corner stone in the 
diagnosis of dilated cardiomyopathy. Material and methods: This study included 48 child with dilated 
cardiomyopathy with LV dysfunction, that diagnosed clinically by history, clinical examination, 
electrocardiography and echocardiography, including 2D-echocardiography, M-mode and Doppler study. Those 
patient were subdivided to 15 child present with acute heart failure (Acute DCM) (8 female and 7 male), and 33 
child who are known cases of dilated cardiomyopathy reported in the cardiology out clinic with chronic LV 
dysfunction (18 female and 15 male) ,both groups followed for one year with regular clinical, laboratory and 
echocardiographic evaluation during treatment coarse for LV dysfunction. another 48 control  healthy child with 
same age groups involved in the study (25 female and 23male), the age of both patient and control groups 
ranging from 1month- 12 years.Results: All patient had  LV dysfunction at the time of attendance . In this study, 
most patient that had  DCM  with acute LV dysfunction had normal weight and height at the time of attendance, 
but after one year , those with LV dysfunction in spite of treatment had defective weight and height, but those 
with chronic LV dysfunction, that develop normal cardiac function after one year of treatment will improve their 
weight and height after one year treatment and follow up.Conclusions: Most children with chronic dilated 
cardiomyopathy have delayed growth regarding weight and height with decrease hemoglobin level .The 
improvement in the cardiac function of some patients usually followed by increment in their body weight and 
height over the periods of follow up. 
 
Introduction 
The normal growth in children is an indicator of  well being, growth may be defective in many illnesses in  
children (Blecker U, et al 2000), there is defective metabolic process , growth failure is usually multifactorial ,it 
is either due to  increase energy expenditure due to chronic disease process or malabsorption ,or decrease dietary 
intake or psychological problem, two or more of these factors are responsible of growth  retardation in any 
chronic illness .The growth failure is one of the most significant problem in children with dilated 
cardiomyopathy ,one third of those with  DCM have growth failure(Azevedo VM ,et al 2004).  
 
Materials and methods 
The participants belongs to both patients and control groups were selected and examined in the cardiology clinic 
of Karbala pediatric teaching hospital between April 2013 and October 2014, the type of test discussed for the 
parents, starting with history taking especially family history, and presence of familial cardiac disease, some 
questionnaire about  the age and degree of relatives of  both parents, past medical history and antenatal history. 
Then measuring  the weight and the height of the affected child, physical examination that involving measuring 
the temperature by mercury  thermometer, heart  rate with auscultation of the chest and palpation and 
auscultation of the precordium for presence of added sounds, also detection of  partial oxygen pressure  SPO2, 
by using digital pulse oxymeter  planted on terminal warm finger phalanx .  Electrocardiography  (ECG), were 
done for all patients, then ultrasonic examination of the heart by using, 2- D echocardiography, M- mode  for 
assessment of cardiac function  ( EF, FS), camber size, cardiac  wall thickness in addition to Doppler study of 
cardiac valves for detection of valvular complications and presence of regurgitation, and to exclude other cardiac 
wall defects or congenital anomaly. 
 
The Growth Charts 
Growth chart consists of an X axis which is usually age  in years or months and a Y axis  that  changes according 
to the reference age. It can be height  in cm or inches, weight in kg or body  mass index (BMI) in kg/m2. The  X 
axis is usually divided into 12 equal parts (months) for each year, but some countries such as United Kingdome  
use decimal ages where each year is divided into 10 parts. WHO Center  for Disease Control and prevention 
(CDC) use 12 (monthly) divisions for each year (Ockenga, 2005). Standard growth chart has 7 percentile lines 
and include 3d,5th, 10 th, 25 th ,50 th, 75 th and 97 th percentiles (WHO, 2008). 
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Figure ( 1 ) standard WHO growth chart for boys and girls infants 0-12 months. 
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Figure ( 2 )standard WHO growth chart for weight and height  for boys 2- 20 years. 
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Figure  (3) Standard WHO growth chart for weight and height for girls 2-20 years age. 
 
Results 
1-Dilated cardiomyopathy with acute LV dysfunction 
Age distribution in patients and control groups 
The study population included 15 patients had dilated cardiomyopathy (DCM) with acute LV dysfunction and 
the control population consisted of 15 normal subjects. There was insignificant difference in age between  patient 
and control groups (p >0.05) as shown in figure (4).  
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Figure (4):The mean age for patient and control groups. 
Examination of studied group 
Weight and height of the studied  group: 
At time of attendance , all patients and control group had normal weight and height but after one year, 66.7% of 
patients had normal weight and 33.3% had abnormal weight( below the 3d percentile age for weight) while 40% 
had normal height and 60%  of patients had abnormal height (below the 3d percentile for height ) and these 
results are of high statistical significance difference if compare with control group (P<0.01).as shown in table(1) . 
Table(1): The weight and height of patient and control groups. 
Control PATIENTS WITH ACUTE DCM 






at time of 
attendance 
100% 66.7% 80% 53.3% 100% Normal 
Weight kg  0% 33.3% 20% 46.7% 0% Below 3rd  
0% 0% 0% 0% 0% Below 50th  
 0.001** 0.001** 0.001** - P value 
100% 40 % 60% 53.3% 100% Normal 
Height cm  0% 60% 40% 40 % 0% Below 3rd  
0% 0% 0% 6.7% 0% Below 50th  
 0.001** 0.001** 0.001** - P value 
2-Dilated Cardiomyopathy with chronic LV dysfunction  
History of studied group  
Age distribution in patients with DCM with chronic LV dysfunction and control groups 
The study population included 33 patients with dilated cardiomyopathy  (DCM) with chronic LV dysfunction  
and the control population consisted of 33 person . There was insignificant difference in age between  patient and 
control groups (p >0.05) as shown in  figure (5).  
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Examination of studied group 
Weight and height  
Most  patients with chronic DCM had abnormal weight and height and had significant difference with control 
group (P<0.01),regarding patients weight, at the time of attendance ,15.2% of patients with chronic DCM were 
have normal body weight, 69.7% of patient with DCM were below the 3d percentile (age for weight percentile), 
and 15.2% were below the 50th percentile for weight , while after one year 30.3% of  patient had normal 
weight ,60.6%  were below the 3d percentile with 9.15 of patients were below the 50th percentile for weight, and 
these results carried a high significant value  .as shown in table(2). 
Regarding patient height, at the time of attendance, 12.1% of children with chronic dilated 
cardiomyopathy had normal height , 54.5% were below the third percentile for height (age for height) and 33.3% 
were below the 50th  percentile , after one year, 18.2% of patients had normal height ,63.6% were below the 3d 
percentile, while 18.2% were below the50th percentile, and these results also are of statistically highly 
significant values as shown in table (2). 
Table(2): The weight and height of patient and control groups. 
Control Patients With Chronic DCM 
GROWTH  
after 1 years after 6 months 
at time of 
attendance 
100% 30.3% 9.1% 15.2% Normal 
Weight kg  0% 60.6% 69.7% 69.7% Below 3rd  
0% 9.1% 21.2% 15.2% Below 50th  
 0.001** 0.001** 0.001** P value 
100% 18.2% 9.1% 12.1% Normal 
Height cm 0% 63.6% 60.6% 54.5% Below 3rd  
0% 18.2% 30.3% 33.3% Below 50th  
 0.001** 0.001** 0.001** P value 
3- Patients with acute and chronic DCM 
Age distribution in patients and control groups 
There was insignificant difference in age between  patient with acute and chronic DCM (p >0.05) as shown in 
figure (18). 
 
Figure(6): The mean age for patient with acute and chronic DCM. 
Examination of studied group 
weight and height 
There was a significant difference in weight between patient with acute and chronic DCM at time of attendance, 
after 6 month and after one year (p <0.05) as shown in figure (19).  
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Figure (7):Weight in patient with acute and chronic DCM 
Also There was  a significant difference in height between  patient with acute and chronic DCM at time of 
attendance and after 6 month (p <0.05) as shown in figure (20). 
 
Figure (8):Height  in patient with acute and chronic DCM 
 
Discussion 
1- Dilated cardiomyopathy with Acute LV dysfunction: 
At time of attendance , all patients and control group had normal weight and height but after one year, 66.7% of 
patients had normal weight and 33.3% had abnormal weight( below the 3d percentile age for weight) while 40% 
had normal height and 60%  of patients had abnormal height (below the 3d percentile for height ) as shown in 
table (1) ,this is  probably because of the fact that ,the heart is the vital organ that affect the growth through 
providing the perfect blood supply to all body organs and cells ,so  the when there is decreasing in left 
ventricular function for long time, this will affecting blood supply to vital organs which interfere with nutrient 
absorption and growth of the child  and this is consistent with other studies, that clarify the effect of heart failure 
on  height and weight  of the  growing child .When there is a process of chronic disease affecting the child 
during the period of growth , the first to be affected is the weight parameter for the same causes mentioned 
before, the height parameter will be affected later on .In this study, about two third of the affecting child had 
their normal weight after one year (66.7%), due to the  improvement in the cardiac function during one year of 
treatment , while about one third ( 33.3%), shows abnormal weight because of the still low cardiac function, and 
this what we found and is consistence with what other studies found like .While after one year treatment only 
40% of the affected child had normal height and 60% had abnormal height, which may be due to the fact that, 
significant cardiac dysfunction affecting those children, resulting in malabsorption, decrease food intake, with 
high metabolic demand, leading to growth failure, which may be partially reversible ,leading to delayed growth 
and abnormal height  for more than two third of patients after one year and this consistent with other studies. 
2- Dilated cardiomyopathy with acute LV dysfunction: 
Most  patients with chronic DCM had abnormal weight and height and had significant difference with control 
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group ,regarding patients weight, at the time of attendance , only 15.2% of patients with chronic DCM were have 
normal body weight , 69.7% of patient with DCM were below the 3d percentile (age for weight percentile)  ,and 
15.2% were below the 50th percentile for weight, while after one year 30.3% of  patient had normal 
weight ,60.6%  were below the 3d percentile with 9.1% of patients were below the 50th percentile for weight, and 
these results carried a high significant value as shown in (table 2) ,this is most probably due to the long standing 
time of cardiac dysfunction that interfere with normal function of other systems including 
renal ,gastrointestinal ,endocrine and nervous system ,leading to decrease absorption of nutrients from intestine 
with low renal and endocrine function ,also it is mention that energy expenditure shown to be increased in 
children with chronic heart failure ,all these factors will affect growth (weight and height) , and this is consistent 
with the study of.  Regarding patient height, at the time of attendance, 12.1% of children with chronic dilated 
cardiomyopathy had normal height, 54.5% were below the third percentile for height (age for height) and 33.3% 
were below the 50th  percentile , after one year, 18.2% of patients had normal height ,63.6% were below the 3d 
percentile, while 18.2% were below the50th percentile as shown in ( table 2) , most probably for the same causes 
mention above . 
 
Conclusions 
Most children with chronic dilated cardiomyopathy have delayed growth regarding weight and height with 
decrease hemoglobin level as compared with growth percentile  for both Weight and Height and with normal 
hemoglobin level. The improvement in the cardiac function of some patients usually followed by increment in 
their body weight and height over the periods of follow up according to the growth charts of weight and height 
for their ages. 
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